For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Arch Development Corporation

USPTO Granted Patents = 349

CIPO Patents = 2

EPO Patents = 4

Forward Citations = 12,107

Loading Chart...

Loading Chart...

346 inventors (with patents filed for the assignee):

Kunio Doi (42 out of 58 patents)

Maryellen L Giger (25 out of 40 patents)

Bernard Roizman (24 out of 39 patents)

4. E Philip Horwitz (15 out of 43 patents)

5. Ralph R Weichselbaum (14 out of 34 patents)

6. Kenneth C Gross (14 out of 21 patents)

7. Heber MacMahon (12 out of 15 patents)

8. Shigehiko Katsuragawa (12 out of 16 patents)

9. Donald W Kufe (11 out of 59 patents)

10. Shutsung Liao (11 out of 13 patents)

11. Stephan W Wegerich (10 out of 33 patents)

12. Robert H Haselkorn (10 out of 11 patents)

13. Piotr Gornicki (9 out of 11 patents)

14. Vikas P Sukhatme (8 out of 33 patents)

15. F Gary Toback (8 out of 18 patents)

Core Competencies:

Genetically Engineered Viruses

Tyrosine Kinase Inhibitors

Amyloid Protein Folding

HER2 Receptor Therapy

Opioid Receptor Modulation

Doped Semiconductor Nanocrystals

Gene Therapy

Optical Gradient Forces

Pulmonary Nodule Detection

Chromosomal Aberrations

Controlled Release Compositions

Image Processing Techniques

349 patents: Sort by Forward Citations

1. 8772261 - Treatment of tumors with genetically engineered herpes virus (2014-07-08),

2. 8318691 - Treatment of tumors with genetically engineered herpes virus (2012-11-27),

3. 7838512 - DNA damaging agents in combination with tyrosine kinase inhibitors (2010-11-23),

4. 7799535 - Methods for identifying factors that control the folding of amyloid proteins of diverse origin (2010-09-21),

5. 7306801 - Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein (2007-12-11),

6. 7235366 - Methods of identifying agonists and antagonists of opioid receptors (2007-06-26),

7. 7227177 - Doped semiconductor nanocrystals (2007-06-05),

8. 7192711 - Compositions and methods involving methyladenosine phosphorylase in the diagnosis and treatment of proliferative disorders (2007-03-20),

9. 7184582 - Method, system and computer readable medium for an intelligent search workstation for computer assisted interpretation of medical images (2007-02-27),

10. 7169764 - Promoter for smooth muscle cell expression (2007-01-30),

11. 7133203 - Apparatus for applying optical gradient forces (2006-11-07),

12. 7115258 - Vesicular monoamine transporter gene therapy in parkinson's disease (2006-10-03),

13. 7078396 - Method of treating disorder related to high cholesterol concentration (2006-07-18),

14. 7078387 - [object Object] (2006-07-18),

15. 7070968 - DNA damaging agents in combination with tyrosine kinase inhibitors (2006-07-04),

Arch Development Corporation is a leading construction and real estate development firm based in New York City. With over 20 years of experience, we specialize in designing and building commercial and residential properties that enrich communities and exceed expectations. Our team of skilled architects, engineers, and contractors work closely with clients to deliver innovative and sustainable solutions. Visit our website to explore our portfolio and learn more about our commitment to quality, integrity, and customer satisfaction.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

349 Patents

#25 in Chicago, IL

#76 in Illinois

#1,243 in US

#2,529 in the World

Chicago, IL, United States of America

Arch Development Corporation

Forward Citations = 12,107

346 inventors:

Kunio Doi (42 out of 58 patents)

Maryellen L Giger (25 out of 40 patents)

Bernard Roizman (24 out of 39 patents)

4. E Philip Horwitz (15 out of 43 patents)

5. Ralph R Weichselbaum (14 out of 34 patents)

Please report any incorrect information to support@idiyas.com

Loading…